Starpharma Holdings Ltd Announce New Indication for VivaGel(R): Bacterial Vaginosis

Melbourne, July 9, 2008 (ABN Newswire) - Starpharma Holdings Limited (ASX:SPL)(PINK:SPHRY) today announced that it will add the treatment of bacterial vaginosis (BV) to the development program for its vaginal microbicide VivaGel(R).